Ackman says buying Salix at $170 is a mistake

Billionaire investor William Ackman says it’s a mistake to buy Salix Pharmaceuticals stock at $170, after the company received a buyout bid from Endo International on Wednesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.